The center, which will be underneath the Yale School of Medicine, will be funded by the university’s psychiatry department. Research will be spearheaded by Dr. Deepak Cyril D’Souza and psychiatry professor Albert Kent, who is also a leading expert on the pharmacology of cannabinoids. D’Souza, the director of the Schizophrenia Neuropharmacology Research Group at Yale University, has previously told News 8 that there are links between youth cannabis use and an increase in mental health conditions and addiction. D’Souza said there is an increasing number of women using cannabis during pregnancy in order to combat morning sickness. However, it’s not currently known what impact that has on the fetal brain. The center will also look at the impact on the elderly.
Source: WTNH.com